Physician profile
Katie Worthington
NPI 1770950727
$24,758.17
in general payments reported to CMS, 2019-2025
17 companies · $9,021 in 2025
The $9,021 reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,780 · 2022: $4,835 · 2023: $2,095 · 2024: $5,026 · 2025: $9,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $2,500 · Travel and Lodging: $2,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,627.54 |
| Consulting Fee | $2,500.00 |
| Travel and Lodging | $2,015.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $15,064.61 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Medtronic, INC. | $6,534.00 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $1,263.21 | 2021-2025 | Navitor, Mitraclip, Cardiomems |
| Aop Health US, LLC | $509.74 | 2025 | Rapiblyk |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $372.50 | 2021-2023 | Lifevest |
| Cardiva Medical, INC. | $221.93 | 2024-2025 | Savvywire, Other, Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $201.84 | 2022-2025 | |
| Boston Scientific Corporation | $162.00 | 2022-2025 | Watchman Flx, Cds - Mct/Cem Monitoring |
| Abiomed | $146.10 | 2025 | |
| W. L. Gore & Associates, INC. | $119.35 | 2021-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Astrazeneca Pharmaceuticals Lp | $40.69 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Irhythm Technologies, INC. | $34.15 | 2024 | Zio Monitor, Zio Xt Patch |
| Philips North America LLC | $25.60 | 2025 | Extended Holter |
| Novartis Pharmaceuticals Corporation | $21.45 | 2024 | |
| Janssen Pharmaceuticals, INC | $14.08 | 2024 | Xarelto |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.92 | 2023 | Xifaxan |
| Haemonetics Corporation | $13.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Worthington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.